A gut microbiome-derived risk score is associated with future cancer development
This study demonstrates that a gut microbiome-derived risk score, based on 28 microbial species, can predict the future development of cancer up to a decade before diagnosis, highlighting the microbiome's potential as a novel biomarker for early cancer risk stratification.